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Introduction. Uterine artery embolization (UAE) is a minimally invasive intervention that is used in the treatment of fibroids. UAE
can lead to complications including postembolization syndrome, postprocedure pain, infection, endometrial atrophy leading to
secondary amenorrhea, and uterine necrosis. Uterine necrosis after UAE is very rare and hence poses a clinical dilemma for any
clinician in its identification andmanagement.We document a case of uterine necrosis after UAE and conduct a literature review on
its causation, clinical features, and management principles. Case. A patient presented one month after UAE with abdominal pain
and abdominal vaginal discharge. Her work-up revealed features of possible uterine necrosis with sepsis and she was scheduled
for a laparotomy and a subtotal hysterectomy was performed. She was subsequently managed with broad spectrum antibiotic and
recovered well. Conclusion. Uterine necrosis after UAE is a rare occurrence and we hope the documentation of this case will add
to the body of knowledge around it. Theories that explain its occurrence include the use of small particles at embolization, the
use of Contour-SE a spherical poly-vinyl alcohol, and lack of collateral supply to the uterus. Its symptoms may be nonspecific but
unremitting abdominal pain is invariably present. Finally although conservative management may be successful at times, surgical
management with hysterectomy will be required in some cases. The prognosis is good after diagnosis and surgical management.
1. Introduction
Uterine artery embolization (UAE) is a minimally invasive
intervention that is used in the treatment of fibroids [1]. UAE
has been used for reduction of fibroid symptoms especially
menorrhagia and offers relief to women not keen on surgical
intervention [2, 3]. More so, UAE has been shown to be
effective in reduction of fibroid symptoms and is also cost
effective when compared to surgical management [4, 5].
Although its cost effectiveness has been disputed recently
when compared to surgical interventions for myomas, UAE
still remains a viable option for treatment of symptoms
of leiomyomas [6, 7]. UAE has contraindications including
pregnancy and malignancy, with relative contraindications
including existing fertility desires and large myomas that are
more than 8–10 centimeters [8].
UAE has various complications associated with it
that vary from minor to major [7, 9]. These include
postembolization syndrome, postprocedure pain, infection,
persistent PV (per vaginam) discharge, fibroid passage PV,
endometrial atrophy leading to secondary amenorrhea,
nontarget embolization, and uterine necrosis [6]. UAE has
also been associated with altered reproductive outcomes
due to its associated altered ovarian function and premature
ovarian failure in some cases [4, 9]. The rates of these
complications vary from around 5.7% for intraprocedural
complications, 37.3% for minor complications, and around
5% for major complication within the first year after UAE [7].
These complications may be comparable in rate to the ones
of surgical management of fibroids which has a complication
rate of 6.3% for intraprocedural complications, 23% for
minor complications, and around 7% for major complication
within the first year after [6]. However, uterine necrosis after
UAE remains one of the rarest complications of UAE with
only about 19 cases documented from the advent of UAE
[10].
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Figure 1: Necrosed uterus (a) and matted Necrosed Myomas (b). Serosal adhesions to small and large bowel (c).
Uterine necrosis after UAE poses a clinical dilemma for
any clinician in its identification and management [10, 11].
The hypotheses of its pathophysiology include the use of very
small particles in UAE (<500 microns) and lack of arterial
anastomoses to embolized regions among other theories [10].
The technical risk factors of necrosis also include unselective
embolization and embolization till stasis is achieved [8, 10].
Uterine necrosis after UAE has few cases that are doc-
umented in literature. Moreover, it offers a diagnostic and
management dilemma to clinicians when it occurs hence
outlining its clinical significance. We document a case of
uterine necrosis after UA and conduct a literature review on
its causation, clinical features, and management principles.
2. Case
A 56-year-old African woman presented with symptoms of
severe abdominal pain and brownish foul smelling vaginal
discharge that had lasted for one month after UAE. She had
associated symptoms of nausea and persistent vomiting but
reported no fever or any other flu like symptoms. She had
an associated nonproductive cough but no other respiratory
symptoms.
She had a UAE done a month prior due to symptomatic
uterine fibroids with her symptoms being menorrhagia and a
feeling of an abdominal mass for a duration of one year. Her
Pre-UAEMRi had shownmultiple enhancing uterine fibroids
numbering around 15 with the largest being around 6.5 cen-
timeters. The UAE had been done with Spongostan Gelfoam
slurry and she was discharged home after an overnight stay.
Her discharge meds after UAE included antibiotics (cefurox-
ime and clindamycin for a week), analgesics (diclofenac and
paracetamol), andmetoclopramide as an antiemetic. She had
been seen 2 weeks after the UAE with no major complaints
with abdominal pain being minimal. This pain worsened
afterwards and was associated with a fever that resolved after
an antibiotic course (clindamycin and metronidazole).
Her known comorbidities were diabetes mellitus for a
duration of 3 years and hypertension for a duration of 5 years
for which she was being treated with lorsartan 50 milligrams
once daily. She had not had any prior surgeries and had no
other significant history in her past.
On examination she was in good general condition
and was oriented in time and place. Her vitals revealed a
tachycardia with a pulse of 107 beats per minute with a
normal bloodpressure of 104/67millimeters ofmercury and a
temperature of 36.2 degrees Celsius. Abdominal examination
revealed lower abdomen tenderness with a palpable pelvic
mass at 14weeks.The rest of her systemswere normal in signs.
Investigations done included a full blood count which
revealed a low hemoglobin level at 9.4 grams per deciliter
with a normal white cell and platelet count. Her urea,
creatinine, and electrolytes were all within normal limits.
She had a chest X-ray done that revealed interstitial edema
with borderline cardiomegaly and a subsequent computed
tomography pulmonary angiogram revealed no evidence of
pulmonary embolism.
In view of her worsening condition with first-line treat-
ment and nonremitting abdominal pain, it was decided that
a surgical intervention would be appropriate and since she
was postmenopausal, a total hysterectomy was advised. She
was subsequently scheduled for the surgery which was done
on day 2 of admission. Intraoperatively we found a Necrosed
uteruswith a thin serosal separation thatwas adhered to small
and large bowel (Figure 1). NecrosedMyomas were found as a
distinct single matted mass of around 12 myomas (Figure 2).
Multiple small pelvic abscesses were also found. A general
surgery team was invited to assist in her surgery at this point.
The surgery done entailed drainage of the pelvic abscesses,
separation of the adhered uterine wall serosa from small
bowel, and a subtotal hysterectomy. Peritoneal lavage was
done with around 10 liters of 0.9% sodium chloride solution.
Bilateral Jackson Pratt drains were left in situ in both pelvic
gutters to drain the pelvis.
Postoperatively, she was started on intravenous antibi-
otics (piperacillin, tazobactam, and clindamycin) and analge-
sia and thromboprophylaxis with enoxaparin. She required a
relook laparotomy on day 4 after surgery due to wound sepsis
in which she had abdominal washouts and fascial closure.
Her skin incision was left open for subsequent dressing and
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Figure 2: Matted Necrosed Myomas and the uterus (d) after
extraction from the subtotal hysterectomy.
secondary wound closure. Her wound swab had a positive
culture of Klebsiella pneumoniae sensitive to Meropenem
which she was started on postoperatively. She recovered as
an inpatient for a further 10 days and was subsequently
discharged after 16 days of admission.
At her follow-up at the clinic 2 weeks afterwards, she
reported marked improvement with no major concerns.
She underwent subsequent wound dressing and the wound
healed well and did not require secondary closure. She was
discharged from follow-up care about 3 months after the
surgery.
3. Discussion
Uterine necrosis after UAE is a rare complication. The
outlined case report documents it and offers insight towards
salient feature of its management.
The exact incidence of uterine necrosis after UAE is
difficult to ascertain with only a handful of cases reported in
literature [6, 10]. The exact pathophysiology of its causation
is not well known although there are a few theories that
try to explain why it occurs [10]. The first theory postulates
that use of fine particles (<500 micrometers) may predispose
to post-UAE necrosis since they may embolize even the
collateral supply to the uterus provided by the cervicovaginal
and utero-ovarian vessels [12]. The other theory postulates
that use of a specific spherical poly-vinyl alcohol agent
(PVA) as an embolizing agent may also predispose to uterine
necrosis [13]. Moreover, patients who do not have good
collateral anastomosis between uterine and ovarian arteries
at embolization may also be at increased risk of necrosis and
hence embolization is avoided if one sees collaterals at the
catheter position [14]. Additionally, nonselective emboliza-
tion during UAE and embolization till stasis also predispose
to uterine necrosis and so selective embolization is also a
key factor in trying to prevent necrosis [8, 10]. Lastly other
theories that exist include the lack of antibiotic prophylaxis
after UAE and the existence of sepsis [15].The current patient
had gelatin used for her embolization and the size of the
particles was larger than 500 micrometers; she also had
collateral anastomosis to the uterus and we used antibiotic
prophylaxis after UAE and hence none of the postulated
theories seem to explain the occurrence of uterine necrosis
in her.
The symptoms of uterine necrosis may be nonspe-
cific. Most commonly the reported clinical picture includes
abdominal pain, fever, leucorrhea, and menorrhagia at times
[10]. Patients may also present with symptoms of sepsis if
concurrent infection is present [7]. The current patient had
most of the above symptomswith abdominal pain and abnor-
mal discharge; she was however not septic at presentation.
Other symptoms may occur with nontarget embolization
leading to concurrent necrosis of adjacent organs such as
the bladder, adnexa, vagina, or even the labia which have
all been reported in literature [14, 16]. The current patient
had no other concurrent organs involved and hence did
not have target symptoms of these organs. Clinical acumen
and ultrasound may be sufficient in the diagnosis of uterine
necrosis after UAE although additional imaging such as a
computed tomography scan andmagnetic resonance imaging
may help in its diagnosis [10, 16]. The current patient did
not have any preoperative scans and a clinical diagnosis was
sufficient.
The treatment of uterine necrosis usually involves either
removal of the Necrosed portion of the uterus and myomas
or a hysterectomy [15, 17]. Conservativemanagement has also
been described in literature as an option for a handful of
patients [18]. The choice of the option of treatment largely
depends upon the severity of symptoms of necrosis and asso-
ciated complications [11, 15]. The current patient had severe
abdominal pain and also had failed conservativemanagement
with antibiotics and oral analgesics, hence the decision for
surgery and hysterectomy. Additional measures that seem to
aid in the good outcome of such patients are the treatment
of concurrent infection with broad spectrum antibiotic and
multidisciplinary management in cases of adjacent organ
involvement [15, 16]. The current patient had concurrent
antibiotics after the surgery due to sepsis and also had a
surgical team involved in her treatment and subsequently
seemed to recover well.
In conclusion, uterine necrosis after UAE is a rare occur-
rence and we hope the documentation of this case will add
to the body of knowledge around it. Theories that explain its
occurrence include the use of small particles at embolization,
the use of Contour-SE a spherical poly-vinyl alcohol, and
lack of collateral supply to the uterus. Its symptoms may
be nonspecific but unremitting abdominal pain is invariably
present. Finally although conservative management may be
successful at times, surgical management with hysterectomy
will be required in some cases. The prognosis is good after
diagnosis and surgical management.
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